John P Devine
CIK 1531244 · View on SEC EDGAR ↗
First SEC filing: Sept. 30, 2011 · Latest: Sept. 30, 2011
On this page
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| June 13, 2014 | NOTV | S | 3,130 | $2.64 | $8,263 | 0 Direct | -100.00% | Disposed | |
| June 13, 2014 | NOTV | S | 3,130 | $2.64 | $8,263 | 0 Direct | -100.00% | Disposed |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Aug. 25, 2014 | NOTV | Option to Purchase Common Shares | Common Shares (2,500) | $1.01 | Aug. 15, 2020 | 2,500 | Disposed |
| March 3, 2014 | NOTV | Option to Purchase Common Shares | Common Shares (5,000) | $1.01 | Aug. 15, 2020 | 5,000 | Disposed |
| Jan. 16, 2013 | NOTV | Option to Purchase Common Shares | Common Shares (500) | $1.40 | Jan. 16, 2023 | 500 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 4 holdings
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| Sept. 30, 2011 | NOTV | Common Shares | 100 | Direct |
| Sept. 30, 2011 | NOTV | Option to Purchase Common Shares→ Common Shares (4,000) | 4,000 | Direct |
| Sept. 30, 2011 | NOTV | Option to Purchase Common Shares→ Common Shares (5,000) | 5,000 | Direct |
| Sept. 30, 2011 | NOTV | Option to Purchase Common Shares→ Common Shares (10,000) | 10,000 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CIK 720154
Jr., Vice President, Toxicology (9)| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2012 | $145,000 | — | — | — | — | — | — | $145,000 |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.